论文部分内容阅读
有些文献报道长期服用阿斯匹林对冠心病患者有效益。Elwood 等采用随机双盲试验,给新近发生过心肌梗塞的患者口服阿斯匹林(300毫克/日)或安慰剂,提示阿斯匹林有减低死亡率的倾向,但这些结果未达统计学意义。冠心病药物研究规划阿斯匹林小组也曾作随机双盲试验,给心肌梗塞后存活的患者口服阿斯匹林(972毫克/日)或安慰剂,结果是
Some reports have reported long-term use of aspirin in patients with coronary heart disease benefit. Elwood et al used a randomized, double-blind trial of oral aspirin (300 mg / day) or placebo in patients with recent myocardial infarction, suggesting that aspirin has a propensity to reduce mortality but these results are not statistically significant significance. The aspirin group also conducted a randomized, double-blind trial of aspirin (972 mg / day) or placebo to patients who survived myocardial infarction, with the result that